Qin, S.; Cheng, A-L.; Ducreux, M. P. et al.
IMbrave150: A randomised phase III study of atezolizumab 1 bevacizumab vs sorafenib in locally advanced or metastatic hepatocellular carcinomaANNALS OF ONCOLOGY. Bd. 29. 2018
Finn, Richard S.; Ducreux, Michel; Qin, Shukui et al.
IMbrave150: A randomized phase III study of 1L atezolizumab plus bevacizumab vs sorafenib in locally advanced or metastatic hepatocellular carcinoma.JOURNAL OF CLINICAL ONCOLOGY. Bd. 36. H. 15. 2018
Weber, Matthias M.; Fottner, Christian
Immune Checkpoint Inhibitors in the Treatment of Patients with Neuroendocrine NeoplasiaONCOLOGY RESEARCH AND TREATMENT. Bd. 41. H. 5. 2018 S. 306-312
Moehler, M.
Immuno-Oncology in gastric cancer: Soon standard? If so, for whom and when?ONCOLOGY RESEARCH AND TREATMENT. Bd. 41. 2018 S. 268-268
Stein, Alexander; Moehler, Markus; Trojan, Joerg et al.
Immuno-oncology in GI tumours: Clinical evidence and emerging trials of PD-1/PD-L1 antagonistsCRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. Bd. 130. 2018 S. 13-26
Moehler, Markus
Immunotherapy in Gastrointestinal Carcinoma - How to Separate Hope from HypeONCOLOGY RESEARCH AND TREATMENT. Bd. 41. H. 5. 2018 S. 264-265
Alsina, Maria; Moehler, Markus; Lorenzen, Sylvie
Immunotherapy of Esophageal Cancer: Current Status, Many Trials and Innovative StrategiesONCOLOGY RESEARCH AND TREATMENT. Bd. 41. H. 5. 2018 S. 266-271
Heinrich, Bernd; Czauderna, Carolin; Marquardt, Jens U.
Immunotherapy of Hepatocellular CarcinomaONCOLOGY RESEARCH AND TREATMENT. Bd. 41. H. 5. 2018 S. 292-297
Herzer, Kerstin; Gerken, Guido; Kroy, Daniela et al.
Impact of direct-acting antiviral therapy on the need for liver transplantation related to hepatitis C in GermanyJOURNAL OF HEPATOLOGY. Bd. 69. H. 4. 2018 S. 982-984
Cook, Nigel; Balp, Maria-Magdalena; Weiss, Olivia et al.
Impact of Non-Alcoholic Steatohepatitis (NASH) on Patients' Quality of Life: Results from a Patient Preference StudyHEPATOLOGY. Bd. 68. 2018 S. 1001A-1002A